Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs201298080 | chr1:49039231 | TG/T | 1.31E-6 | 129 | 37.3 | 111.63 | 0.57 | KM Plot |
| TGCT | rs201385093 | chr16:67600349 | G/GTTGC | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs201580887 | chr2:3487331 | T/TCTC | 2.43E-5 | 131 | 40.57 | 66.17 | 25.32 | KM Plot |
| TGCT | rs201784438 | chr20:58139912 | CAGAA/C | 3.59E-13 | 130 | 40.57 | 79.62 | 17.1 | KM Plot |
| TGCT | rs202080011 | chr20:58140004 | GAGAC/G | 2.79E-13 | 131 | 39.38 | 79.62 | 17.1 | KM Plot |
| TGCT | rs2025249 | chr6:42568248 | A/G | 7.34E-7 | 134 | 27.03 | 49.93 | 37.62 | KM Plot |
| TGCT | rs2025250 | chr6:42572494 | G/A | 2.74E-8 | 133 | 20.6 | 51.67 | 37.7 | KM Plot |
| TGCT | rs2027362 | chr6:28332698 | T/C | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |
| TGCT | rs2039625 | chr9:71484439 | A/T | 8.87E-6 | 134 | 160.53 | 32.58 | 42.1 | KM Plot |
| TGCT | rs2049836 | chr8:116909621 | G/T | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs2072318 | chr6:28348418 | A/G | 0 | 133 | 46.07 | 29.65 | 0.57 | KM Plot |
| TGCT | rs2072319 | chr6:28348660 | T/C | 0 | 133 | 46.07 | 29.65 | 0.57 | KM Plot |
| TGCT | rs2096404 | chr13:78234988 | T/G | 1.1E-5 | 132 | 15.7 | 35.37 | 42.18 | KM Plot |
| TGCT | rs2105439 | chr13:78235317 | T/C | 1.22E-5 | 131 | 15.7 | 35.37 | 42.1 | KM Plot |
| TGCT | rs2111826 | chr3:170140846 | A/G | 5.69E-5 | 128 | 21.13 | 36.63 | 42.18 | KM Plot |